Anti-Zika virus(ZIKV)(strain Zika SPH2015) ZIKV-NS1 Monoclonal Antibody
| Code | Size | Price |
|---|
| E-AB-V1338-50uL | 50uL | £244.00 |
Quantity:
| E-AB-V1338-100uL | 100uL | £354.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Mouse
Antibody Isotype: IgG1
Antibody Clonality: Monoclonal
Antibody Clone: 15
Regulatory Status: RUO
Target Species: Zika Virus (ZIKV)
Applications:
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Western Blot (WB)
Shipping:
Ice packs
Storage:
Store at -20°C. Avoid freeze / thaw cycles.
Further Information
Background:
Zika virus NS1 antigen is one of seven non-structural proteins. NS1 is involved in RNA replicaiton. The possible effects of NS1 on hosts include: localization to host cell surface and secreted extracellularly, modelates signalling of innate immune system, has possible damages to platelets and endothelial cells through anti-NS1 antibodies.
Buffer:
0.2 um filtered solution in PBS
Concentration:
1mg/mL
Conjugation:
Unconjugated
Dilution:
WB 1:1000-1:5000 ELISA 1:1000-1:2000
Immunogen:
Recombinant ZIKV (strain Zika SPH2015) NS1 protein (N-His Tag)
Purification method:
Protein A Affinity
Target Synonym:
NS1
Related Products
| Product Name | Product Code | Supplier | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Immunogen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Recombinant ZIKV (strain Zika SPH2015) NS1 protein (N-His Tag) | PKSV030272 | Elabscience | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||